Free Trial
NASDAQ:EKSO

Ekso Bionics Q1 2025 Earnings Report

Ekso Bionics logo
$0.48 0.00 (-0.17%)
Closing price 05/2/2025 04:00 PM Eastern
Extended Trading
$0.49 +0.01 (+1.04%)
As of 05/2/2025 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Ekso Bionics EPS Results

Actual EPS
N/A
Consensus EPS
-$0.11
Beat/Miss
N/A
One Year Ago EPS
N/A

Ekso Bionics Revenue Results

Actual Revenue
N/A
Expected Revenue
$4.62 million
Beat/Miss
N/A
YoY Revenue Growth
N/A

Ekso Bionics Announcement Details

Quarter
Q1 2025
Time
After Market Closes
Conference Call Date
Monday, May 5, 2025
Conference Call Time
4:30PM ET

Conference Call Resources

Ekso Bionics Earnings Headlines

StockNews.com Initiates Coverage on Ekso Bionics (NASDAQ:EKSO)
Trump’s treachery
Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.
See More Ekso Bionics Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Ekso Bionics? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Ekso Bionics and other key companies, straight to your email.

About Ekso Bionics

Ekso Bionics (NASDAQ:EKSO) designs, develops, sells, and rents exoskeleton products in the Americas, Germany, Poland, Europe, the Middle East, Africa, the Asia Pacific, and internationally. It operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, and markets exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods. The company provides EksoNR, a wearable bionic suit and rehabilitation device that assists physical therapists and physicians to treat patients with acquired brain injury, stroke, and spinal cord injury; Ekso Indego Therapy, an adjustable and lower-limb powered exoskeleton; Ekso Indego Personal, a powered lower limb orthosis; Ekso Nomad, a power knee ankle foot orthosis; and Ekso EV, a wearable upper body exoskeleton that elevates and supports a worker's arms to assist with tasks from chest height to overhead. Ekso Bionics Holdings, Inc. was founded in 2005 and is headquartered in San Rafael, California.

View Ekso Bionics Profile

More Earnings Resources from MarketBeat